QuickView for uo126 (compound)

1. Monocyte-derived dendritic cells treated with MEK inhibitor U0126 or p38/MAPK inhibitor SB203580
2. NIH-3T3 mouse embryonic fibroblasts expressing RasV12 treated with interferon-alpha or U0126
3. Mammary gland cancer after SHP2 knockout or SHP2 signaling inhibition
4. Fibroblasts treated with U0126 and insulin
5. Monocyte response to stimulation by serum in the presence or absence U0126

1. Nonwoven-based gelatin/polycaprolactone membrane loaded with ERK inhibitor U0126 for treatment of te…
2. U0126 pretreatment inhibits cisplatin-induced apoptosis and autophagy in HEI-OC1 cells and cochlear …
3. The MEK inhibitor U0126 ameliorates diabetic cardiomyopathy by restricting XBP1's phosphorylation de…
4. Blockade of ERK1/2 activation with U0126 or PEP7 reduces sodium appetite and angiotensin II-induced …
5. An Addition of U0126 Protecting Heart Grafts From Prolonged Cold Ischemia-Reperfusion Injury in Hear…

There were no clinical trials for uo126